Acute viral myocarditis is an extremely diverse disease with a predictable good outcome with supportive therapy. The objective of this study was to look at the clinical outcome of patients receiving additional intrave...Acute viral myocarditis is an extremely diverse disease with a predictable good outcome with supportive therapy. The objective of this study was to look at the clinical outcome of patients receiving additional intravenous gamma globulin compared to those receiving conventional anti-congestive therapy alone. Patients and methods: This is a retrospective review of charts of children admitted with acute myocarditis. Group 1 was children who received intravenous gamma globulin (IVIG) along with conventional anti-congestive therapy. Group 2 were patients who received the conventional anticongestive therapy alone. Short-term outcome was survival to hospital discharge, and mid-term outcome was improvement of left ventricular ejection fraction at 6 months and one year follow-up. Results: A total of 36 patients were enrolled and 18 were males. The mean age of all patients was 2.3 ± 2.6 years and the mean duration of illness for the whole group was 6.7 ± 3.8 days. Group 1 comprised of 16 patients. There was no difference in short-term outcome with mortality of 2 patients in Group1 (12.5%) and 3(15%) in Group 2 (p = 0.2). At intermediate term follow up, recovery of ejection fraction in Group 1 was in 4/14 (28%) and in Group 2 it was 9/17 (55%) and at 12 months it was 10/13 (77%) in Group 1 and 15/16 (94%) in Group 2 (p = 0.02 and 0.19 respectively). Conclusion: Acute myocarditis has a high spontaneous cure rate. Our study did not show any significant difference in the short-term or midterm outcome between children receiving IVIG compared to those who did not.展开更多
目的研究静脉注射用丙种球蛋白(intravenous immunoglobulin for intravenous injection,IVIG)联合抗病毒方案对手足口病(hand foot and mouth disease,HFMD)合并脑炎患儿病程及实验室指标的影响.方法选取2016年3月~2018年1月本院收治的...目的研究静脉注射用丙种球蛋白(intravenous immunoglobulin for intravenous injection,IVIG)联合抗病毒方案对手足口病(hand foot and mouth disease,HFMD)合并脑炎患儿病程及实验室指标的影响.方法选取2016年3月~2018年1月本院收治的126例HFMD合并脑炎患儿,采用随机数字表法分为对照组及观察组,每组63例.对照组给予抗病毒治疗,观察组在对照组基础上给予IVIG治疗,疗程3~5天.观察两组患儿的实验室指标变化、病程变化及临床疗效情况.结果两组患儿在年龄、性别、病程、儿童类型、居住地等方面差异无统计学意义(P>0.05).两组患儿在治疗前血清碱性磷酸酶(alkaline phosphatase,ALP)、前白蛋白(prealbumin,PA)、白细胞计数(white blood cell count,WBC)、C-反应蛋白(C-reactive protein,CRP)、S100B、神经元特异性烯醇化酶(neuro specific enolase,NSE)及脑脊液S100B、NSE比较差异无统计学意义(P>0.05),治疗后两组患儿ALP、PA均略有增高,观察组略高于对照组但差异无统计学意义(P>0.05),血清WBC、CRP、血清S100B、血清NSE及脑脊液S100B、脑脊液NSE均有所下降且观察组明显低于对照组,差异有统计学意义(P<0.05).观察组患儿退热时间、皮疹消退时间、神经系统症状消失时间均明显短于对照组,差异有统计学意义(P<0.05).对照组总有效率为77.78%,观察组总有效率为96.82%,两组患儿临床疗效有效率差异有统计学意义(P<0.05).结论IVIG联合抗病毒治疗方案能够改善手足口病合并脑炎患儿的实验室指标,缩短各种临床症状的改善时间和病程,临床效果显著.展开更多
目的观察半剂量静脉丙种球蛋白(IVIG)联合长春新碱(VCR)治疗重症新诊断原发免疫性血小板减少症(ITP)的疗效。方法选择2010年9月-2014年9月医院收治的重症ITP患者24例,随机分为2组各12例,A组给予半剂量IVIG联合VCR治疗。B组给予IVIG治疗...目的观察半剂量静脉丙种球蛋白(IVIG)联合长春新碱(VCR)治疗重症新诊断原发免疫性血小板减少症(ITP)的疗效。方法选择2010年9月-2014年9月医院收治的重症ITP患者24例,随机分为2组各12例,A组给予半剂量IVIG联合VCR治疗。B组给予IVIG治疗。2组均同时联合常规剂量糖皮质激素治疗。比较2组疗效。结果治疗前2组PLT水平比较差异无统计学意义(P>0.05),治疗后3、7、14、28、90 d 2组PLT均升高(P<0.05),2组间比较差异无统计学意义(P>0.05)。随访2年A组PLT水平高于B组(P<0.05)。2组总有效率比较差异无统计学意义(P>0.05)。随访2年A组基本治愈率高于B组,差异有统计学意义(P<0.05)。结论半剂量IVIG+VCR可作为治疗重症新诊断ITP的有效方法,值得临床推广。展开更多
文摘Acute viral myocarditis is an extremely diverse disease with a predictable good outcome with supportive therapy. The objective of this study was to look at the clinical outcome of patients receiving additional intravenous gamma globulin compared to those receiving conventional anti-congestive therapy alone. Patients and methods: This is a retrospective review of charts of children admitted with acute myocarditis. Group 1 was children who received intravenous gamma globulin (IVIG) along with conventional anti-congestive therapy. Group 2 were patients who received the conventional anticongestive therapy alone. Short-term outcome was survival to hospital discharge, and mid-term outcome was improvement of left ventricular ejection fraction at 6 months and one year follow-up. Results: A total of 36 patients were enrolled and 18 were males. The mean age of all patients was 2.3 ± 2.6 years and the mean duration of illness for the whole group was 6.7 ± 3.8 days. Group 1 comprised of 16 patients. There was no difference in short-term outcome with mortality of 2 patients in Group1 (12.5%) and 3(15%) in Group 2 (p = 0.2). At intermediate term follow up, recovery of ejection fraction in Group 1 was in 4/14 (28%) and in Group 2 it was 9/17 (55%) and at 12 months it was 10/13 (77%) in Group 1 and 15/16 (94%) in Group 2 (p = 0.02 and 0.19 respectively). Conclusion: Acute myocarditis has a high spontaneous cure rate. Our study did not show any significant difference in the short-term or midterm outcome between children receiving IVIG compared to those who did not.
文摘目的观察半剂量静脉丙种球蛋白(IVIG)联合长春新碱(VCR)治疗重症新诊断原发免疫性血小板减少症(ITP)的疗效。方法选择2010年9月-2014年9月医院收治的重症ITP患者24例,随机分为2组各12例,A组给予半剂量IVIG联合VCR治疗。B组给予IVIG治疗。2组均同时联合常规剂量糖皮质激素治疗。比较2组疗效。结果治疗前2组PLT水平比较差异无统计学意义(P>0.05),治疗后3、7、14、28、90 d 2组PLT均升高(P<0.05),2组间比较差异无统计学意义(P>0.05)。随访2年A组PLT水平高于B组(P<0.05)。2组总有效率比较差异无统计学意义(P>0.05)。随访2年A组基本治愈率高于B组,差异有统计学意义(P<0.05)。结论半剂量IVIG+VCR可作为治疗重症新诊断ITP的有效方法,值得临床推广。
